Canadian Investment Banking Group: Maintaining the Aptose Biosciences (APTO.US) rating, adjusted from buy to buy rating, and adjusted the target price from $15.00 to $6.00.
加拿大投资银行集团：维持Aptose Biosciences(APTO.US)评级，由买入调整至买入评级, 目标价由15.00美元调整至6.00美元。
Canadian Investment Banking Group: Maintaining the Aptose Biosciences (APTO.US) rating, adjusted from buy to buy rating, and adjusted the target price from $15.00 to $6.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.